Effects of heparin-binding protein (CAP37/azurocidin) in a porcine model of Actinobacillus pleuropneumoniae-induced pneumonia

Pharmacological Research

Volumn 51, Issue 6, 2005, Pages 509-514

  Lauritzen, Brian ^a,c   Lykkesfeldt, Jens ^a   Djurup, René ^b   Flodgaard, Hans ^b   Svendsen, Ove ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Leukotech A/S   (Denmark)

^c NOVO NORDISK A S   (Denmark)

Author keywords

Actinobacillus pleuropneumoniae; Heparin binding protein; Pig; Pneumonia

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; AZUROCIDIN; C REACTIVE PROTEIN; HEPARIN BINDING PROTEIN; INTERLEUKIN 6;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; INFLAMMATION; MALE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; RECTUM TEMPERATURE; SWINE;

EID: 17044391793     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2005.01.004     Document Type: Article

References (22)

1. M. Heinzelmann, M.A. Mercer-Jones, J. Peyton, H. Flodgaard, and W.G. Cheadle Heparin binding protein increases survival in murine fecal peritonitis Crit Care Med 28 2000 2926 2931
2. M. Heinzelmann, A. Platz, H. Flodgaard, and F.N. Miller Heparin binding protein (CAP37) is an opsonin for Staphylococcus aureus and increases phagocytosis in monocytes Inflammation 22 1998 493 507
3. H.A. Pereira CAP37, a neutrophil-derived multifunctional inflammatory mediator J Leukoc Biol 57 1995 805 812
4. Gautam N. Mechanisms for leukocyte-mediated adjustment of endothelial barrier function. Ph.D. thesis, Karolinska Institute, Stockholm, Sweden, 2001.
5. N. Gautam, A.M. Olofsson, H. Herwald, L.F. Iversen, E. Lundgren-Akerlund, and P. Hedqvist Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability Nat Med 7 2001 1123 1127
6. O. Chertov, H. Ueda, L.L. Xu, K. Tani, W.J. Murphy, and J.M. Wang Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils J Exp Med 186 1997 739 747
7. H.A. Pereira, W.M. Shafer, J. Pohl, L.E. Martin, and J.K. Spitznagel CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity J Clin Invest 85 1990 1468 1476
8. M. Heinzelmann, M.A. Mercer-Jones, H. Flodgaard, and F.N. Miller Heparin-binding protein (CAP37) is internalized in monocytes and increases LPS-induced monocyte activation J Immunol 160 1998 5530 5536
9. A.M. Olofsson, M. Vestberg, H. Herwald, J. Rygaard, G. David, and K.E. Arfors Heparin-binding protein targeted to mitochondrial compartments protects endothelial cells from apoptosis J Clin Invest 104 1999 885 894
10. M.S. Shrotri, J.F. Kuhn, J.C. Peyton, H.J. Flodgaard, J.B. Klein, and W.G. Cheadle Heparin-binding protein decreases apoptosis in human and murine neutrophils J Surg Res 89 2000 53 59
11. B. Lauritzen, J. Lykkesfeldt, M.T. Skaanild, O. Angen, J.P. Nielsen, and C. Friis Putative biomarkers for evaluating antibiotic treatment: an experimental model of Actinobacillus pleuropneumoniae infection Res Vet Sci 74 2003 261 270
12. H. Flodgaard, E. Ostergaard, S. Bayne, A. Svendsen, J. Thomsen, and M. Engels Covalent structure of two novel neutrophile leucocyte-derived proteins of porcine and human origin. Neutrophile elastase homologues with strong monocyte and fibroblast chemotactic activities Eur J Biochem 197 1991 535 547
13. P.B. Rasmussen, S. Bjorn, S. Hastrup, P.F. Nielsen, K. Norris, and L. Thim Characterization of recombinant human HBP/CAP37/azurocidin, a pleiotropic mediator of inflammation-enhancing LPS-induced cytokine release from monocytes FEBS Lett 390 1996 109 112
14. Flodgaard H, Rasmussen PB, Bjorn S, Svendsen I. Expression of heparin-binding protein in recombinant mammalian cell. Patent WO 00/66627, November 2000.
15. J. Lykkesfeldt Determination of ascorbic acid and dehydroascorbic acid in biological samples by high-performance liquid chromatography using subtraction methods: reliable reduction with tris[2-carboxyethyl]phosphine hydrochloride Anal Biochem 282 2000 89 93
16. W. Sattler, D. Mohr, and R. Stocker Rapid isolation of lipoproteins and assessment of their peroxidaiton by high-performance liquid chromatography postcolumn chemoluminiscence Methods Enzymol 233 1994 469 489
17. S.B. Giese, E. Stenbaek, and R. Nielsen Identification of Actinobacillus pleuropneumoniae serotype 2 by monoclonal or polyclonal antibodies in latex agglutination tests Acta Vet Scand 34 1993 223 225
18. R. Daifuku, H. Movahhed, N. Fotheringham, M.B. Bear, and S. Nelson Time to resolution of morbidity: an endpoint for assessing the clinical cure of community-acquired pneumonia Respir Med 90 1996 587 592
19. F. Dallaire, N. Ouellet, M. Simard, Y. Bergeron, and M.G. Bergeron Efficacy of recombinant human granulocyte colony-stimulating factor in a murine model of pneumococcal pneumonia: effects of lung inflammation and timing of treatment J Infect Dis 183 2001 70 77
20. A. Supersaxo, W.R. Hein, and H. Steffen Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration Pharm Res 7 1990 167 169
21. E. Ostergaard, and H. Flodgaard A neutrophil-derived proteolytic inactive elastase homologue (hHBP) mediates reversible contraction of fibroblasts and endothelial cell monolayers and stimulates monocyte survival and thrombospondin secretion J Leukoc Biol 51 1992 316 323
22. R.S. Hotchkiss, and I.E. Karl The pathophysiology and treatment of sepsis N Engl J Med 348 2003 138 150